Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Oxycodone 5mg modified-release tablets |
| BNF code | 0407020ADAAAKAK |
| Virtual Therapeutic Moiety | Oxycodone |
| Date identifier became valid | 5 Nov 2018 |
| Previous product identifier | 407919006 |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | tablet |
| Unit dose unit of measure | tablet |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Oxycodone hydrochloride |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 5.000 |
| Strength value numerator unit | mg |
| Ontology Drug Form & Route | |
| Form & Route | tabletmodified-release.oral |
| Dose Form | |
| Formulation | Modified-release tablet |
| Drug Route | |
| Route | Oral |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | Schedule 2 (CD) |
| Actual Medicinal Products | |
| Ixyldone 5mg modified-release tablets (Morningside Healthcare Ltd) | |
| Longtec 5mg modified-release tablets (Qdem Pharmaceuticals Ltd) | |
| Oxeltra 5mg modified-release tablets (Wockhardt UK Ltd) | |
| OxyContin 5mg modified-release tablets (Lexon (UK) Ltd) | |
| OxyContin 5mg modified-release tablets (Napp Pharmaceuticals Ltd) | |
| OxyContin 5mg modified-release tablets (Necessity Supplies Ltd) | |
| Oxylan 5mg prolonged-release tablets (G.L. Pharma UK Ltd) | |
| Oxypro 5mg modified-release tablets (Ridge Pharma Ltd) | |
| Reltebon 5mg modified-release tablets (Accord-UK Ltd) | |
| Virtual Medicinal Product Packs | |
| Oxycodone 5mg modified-release tablets 14 tablet | |
| Oxycodone 5mg modified-release tablets 28 tablet | |
dm+d data retrieved from TRUD: release NHSBSA_6.0.0_20240603000001, imported on 3rd June 2024 at 04:58:20.